NO20030407D0 - Silikatformidlet syntese av omorfe silikater og siloksaner og anvendelse avdette - Google Patents

Silikatformidlet syntese av omorfe silikater og siloksaner og anvendelse avdette

Info

Publication number
NO20030407D0
NO20030407D0 NO20030407A NO20030407A NO20030407D0 NO 20030407 D0 NO20030407 D0 NO 20030407D0 NO 20030407 A NO20030407 A NO 20030407A NO 20030407 A NO20030407 A NO 20030407A NO 20030407 D0 NO20030407 D0 NO 20030407D0
Authority
NO
Norway
Prior art keywords
silicate
silicatein
siloxanes
silicates
immorphous
Prior art date
Application number
NO20030407A
Other languages
English (en)
Other versions
NO20030407L (no
Inventor
Werner E G Mueller
Heinz C Schroeder
Bernd Lorenz
Anatoli Krasko
Original Assignee
Anatoli Krasko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anatoli Krasko filed Critical Anatoli Krasko
Publication of NO20030407L publication Critical patent/NO20030407L/no
Publication of NO20030407D0 publication Critical patent/NO20030407D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P3/00—Preparation of elements or inorganic compounds except carbon dioxide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Silicon Polymers (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Silicon Compounds (AREA)
  • Formation Of Insulating Films (AREA)
  • Detergent Compositions (AREA)
NO20030407A 2000-07-28 2003-01-27 Silikatformidlet syntese av omorfe silikater og siloksaner og anvendelse avdette NO20030407D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10037270A DE10037270B4 (de) 2000-07-28 2000-07-28 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung
PCT/EP2001/008423 WO2002010420A2 (de) 2000-07-28 2001-07-20 Silicatein-vermittelte synthese von amorphen silikaten und siloxanen und ihre verwendung

Publications (2)

Publication Number Publication Date
NO20030407L NO20030407L (no) 2003-01-27
NO20030407D0 true NO20030407D0 (no) 2003-01-27

Family

ID=7650838

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030407A NO20030407D0 (no) 2000-07-28 2003-01-27 Silikatformidlet syntese av omorfe silikater og siloksaner og anvendelse avdette

Country Status (11)

Country Link
US (1) US7169589B2 (no)
EP (1) EP1320624B1 (no)
JP (1) JP2004516818A (no)
CN (1) CN1261451C (no)
AT (1) ATE277194T1 (no)
AU (2) AU8971301A (no)
CA (1) CA2414602A1 (no)
DE (2) DE10037270B4 (no)
NO (1) NO20030407D0 (no)
NZ (1) NZ523474A (no)
WO (1) WO2002010420A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003054205A2 (en) * 2001-12-20 2003-07-03 The Procter & Gamble Company Biosynthesis of cyclic siloxanes
US6811145B2 (en) * 2002-05-07 2004-11-02 Edward L. Gibbs Barrier formed by resistance projection welding
DE10240035A1 (de) * 2002-08-30 2004-03-11 Rehm, Bernd H.A., PD Dr.rer.nat. Biogene Polyester-Partikel definierter Größe mit funktionalisierten Oberflächen:Herstellungsverfahren und pharmazeutische Zubereitungen, in denen diese enthalten sind
DE10246186B4 (de) * 2002-10-03 2005-07-07 Johannes-Gutenberg-Universität Mainz Abbau und Modifizierung von Silicaten und Siliconen durch Silicase und Verwendung des reversiblen Enzyms
DE10352433B4 (de) * 2003-11-10 2012-10-11 Nanotecmarin Gmbh Polypeptid eines Silicatein-ß aus Suberites domuncula, dafür kodierende Nukleinsäure, deren Verwendungen, diese Nukleinsäure umfassender Vektor und dieses Polypeptid exprimierende Wirtszelle
US7455998B2 (en) * 2004-03-03 2008-11-25 Dow Corning Corporation Methods for forming structurally defined organic molecules
US8523150B2 (en) * 2004-03-15 2013-09-03 Edward L. Gibbs Fence with tiltable picket
DE102004021229A1 (de) * 2004-04-30 2005-11-24 Heiko Dr. Schwertner Enzymatisches Verfahren zur Herstellung bioaktiver, Osteoblasten-stimulierender Oberflächen und Verwendung
DE102004021230A1 (de) * 2004-04-30 2005-11-24 Heiko Dr. Schwertner Enzym-und Template-gesteuerte Synthese von Silica aus nicht-organischen Siliciumverbindungen sowie Aminosilanen und Silazanen und Verwendung
DE102005061248B4 (de) 2005-12-20 2007-09-20 Infineon Technologies Ag Systemträger mit in Kunststoffmasse einzubettenden Oberflächen, Verfahren zur Herstellung eines Systemträgers und Verwendung einer Schicht als Haftvermittlerschicht
US20100047224A1 (en) * 2006-08-23 2010-02-25 Geurtsen Werner K Biosilica-Adhesive Protein Nanocomposite Materials: Synthesis and Application in Dentistry
EP2248824A1 (en) 2009-04-27 2010-11-10 Matthias Dr. Wiens Use of silintaphin for the structure-directed fabrication of (nano)composite materials in medicine and (nano) technology
EP2246435A1 (en) 2009-04-29 2010-11-03 Consiglio Nazionale delle Ricerche - INFM Istituto Nazionale per la Fisica della Materia Silicon derivate layers/films produced by silicatein-mediated templating and process for making the same
DE102009024603A1 (de) 2009-06-10 2010-12-16 Nanotecmarin Gmbh Enzymatisches Verfahren zur Herstellung von Biosilica als Bestandteil einer bioaktiven Zahnpasta und Verwendung
EP2409710A1 (en) 2010-06-29 2012-01-25 NanotecMARIN GmbH Injectable material and material to be used as drug or food supplement for prophylaxis or treatment of osteoporosis
EP2409682A1 (en) 2010-07-19 2012-01-25 Werner E. G. MÜLLER Hydroxyapatite-binding nano- and microparticles for caries prophylaxis and reduction of dental hypersensitivity
EP2489346A1 (en) 2011-01-26 2012-08-22 NanotecMARIN GmbH Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
DE102016004090A1 (de) 2015-04-16 2016-10-20 Florian Draenert ZUSAMMENSETZUNG ElNES BlOMATERlALS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670438B1 (en) * 1998-12-18 2003-12-30 The Regents Of The University Of California Methods, compositions, and biomimetic catalysts for in vitro synthesis of silica, polysilsequioxane, polysiloxane, and polymetallo-oxanes

Also Published As

Publication number Publication date
EP1320624B1 (de) 2004-09-22
CN1460110A (zh) 2003-12-03
WO2002010420A3 (de) 2003-04-03
DE10037270A1 (de) 2002-02-14
AU8971301A (en) 2002-02-13
US20030134391A1 (en) 2003-07-17
CN1261451C (zh) 2006-06-28
DE10037270B4 (de) 2007-09-13
ATE277194T1 (de) 2004-10-15
AU2001289713B2 (en) 2007-02-01
DE50103793D1 (de) 2004-10-28
CA2414602A1 (en) 2002-02-07
US7169589B2 (en) 2007-01-30
AU2001289713A2 (en) 2002-02-13
EP1320624A2 (de) 2003-06-25
NO20030407L (no) 2003-01-27
WO2002010420A2 (de) 2002-02-07
JP2004516818A (ja) 2004-06-10
NZ523474A (en) 2005-03-24

Similar Documents

Publication Publication Date Title
NO20030407D0 (no) Silikatformidlet syntese av omorfe silikater og siloksaner og anvendelse avdette
HUP0303996A2 (hu) Vakcinakészítmények
RS100403A (en) Triamide substituted indoles,benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mpt) and/or apolipoprotein b(apob) secretion
MXPA00011422A (es) Derivados de bencimidazol como moduladores de ige.
ATE385781T1 (de) Montelukast-granulatformulierung
ATE450619T1 (de) Defructosylierungsverfahren
HUP0302376A2 (hu) Anti-TNF ellenanyagok, készítmények, eljárások és alkalmazások
DE60120151D1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
NO20043102L (no) Fjerning av sure gasser
HK1025511A1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
AU2002216011A1 (en) Method of purifying trichlorosilane
DE60136360D1 (de) Antigen aus streptococcus pyogenes
ATE363474T1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
ATE321853T1 (de) Humanische pellino-polypeptide
DE50308707D1 (de) Abbau und modifizierung von silicaten und siliconen durch silicase und verwendung des reversiblen enzyms
NO20025146L (no) Isolering og karakterisering av csa-operonet (ETEC-CS4 pili) og fremgangsmåter for anvendelse derav
DE60211495D1 (de) Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms
FR2819809B1 (fr) Peptides presentant un affinite pour la proteine virale gp120, et utilisation de ces peptides
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
WO2005045020A3 (de) Enzymatische synthese, modifikation und abbau von silicium(iv)- und anderer metall(iv)-verbindungen
ATE456659T1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
ATE402998T1 (de) D-hydantoinase aus ochrobactrum anthropi
DE60326048D1 (de) Kristallstruktur des angiotensin-konvertierenden enzyms (ace) und ihre verwendung
DE60204014D1 (de) Chlormethylierung von thiophene
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application